Here we take a close look at three upcoming Biotech Stocks which have dominated majority of the news in the Biotech Segment. All three stocks: Clovis, Biogen & Halozyme have shown some promise in the past and would hope to continue their run of form in the coming months. Let’s take a closer look at the three stocks. Clovis’ shares slumped 19.9% on safety concerns … Continue reading Biotech Stocks Roundup: Clovis, Biogen & Halozyme
Here we take a close look at three upcoming Biotech Stocks which have dominated majority of the news in the Biotech Segment. While Sarepta has shown mediocre results in the past few weeks, the stock may be looking for a comeback in the coming times. On the other hand, both Regeneron and Ariad are looking strong as we head into August. Let’s take a closer … Continue reading Biotech Stocks to Target: Sarepta Therapeutics, Regeneron Pharma. & Ariad
AbbVie’s (ABBV) efforts to acquire Ireland-based Shire (SHPG) remains the top news in the biotech market segment. Meanwhile, Gilead Sciences Inc’s (GILD) hepatitis C drug made it to the news yet again thanks to its price tag. Also making it to the news is Clegene Corp. Let’s take a closer look at the three stocks. AbbVie, which has been looking to acquire Shire for a … Continue reading Bullish Biotech Stocks in News: AbbVie, Gilead Sciences Inc & Celgene Corp
In the first quarter of the year, Spain’s largest bank, Grupo Santander SAN , earned EUR 1,205 million, up significantly from the EUR 401 million it earned in the trailing quarter. Most of this increase was due to the non-recurrence of special loan loss provisions in the fourth quarter; excluding this, earnings were up 18% sequentially, but down 26% from the year-ago quarter because of … Continue reading Santander`s First-Quarter Profit Benefits Lower Provisions
It was business as usual for the biotech sector last week with highlights including a deal for the acquisition of product rights, encouraging study results and the granting of breakthrough therapy status for an experimental cancer treatment. Here we take a look at all these news in detail. Regado Biosciences saw its shares plunging 58% on news that a data safety monitoring board (DSMB) is … Continue reading Biotech Stocks Roundup: A look at Regado Biosciences, Jazz Pharmaceuticals & Agenus Inc
In the first quarter, BASF BAS continued to rely on its diversified product mix in what has been a challenging market environment for chemical producers. BASF’s agriculture and oil and gas businesses propped up sales in the first quarter, as revenues increased 4.8% year over year. On a geographic basis, management noted that growth in China was below the firm’s expectations during the quarter. Excluding … Continue reading BASF`s Crop Protection Products Help Boost Results in First Quarter
